SynthesisBMC cardiovascular disorders2024

Early administration of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis.

Kaveh Hosseini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.